Nordic Pharma Consulting ApS: Financial statements 2024
CVR: 37368598
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Nordic Pharma Consulting ApS (CVR 37368598) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 14,101,873 and a net result of DKK 2,966,376 compared with DKK 1,588,832 the year before. That is an increase of 25.8% compared with the year before. Equity in the 2024 report amounted to DKK 3,768,973. The solvency ratio was 46.3%. The company had 8 employees in the financial year.
- Gross Profit
- DKK 14,101,873
- Profit/Loss
- DKK 2,966,376
- Equity
- DKK 3,768,973
- Total Assets
- DKK 8,145,509
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 14.1M | 3M | 3.8M | 8 |
| 2023 | - | 11.2M | 1.6M | 2.4M | 7 |
| 2022 | - | 11.6M | 3.6M | 4.4M | 6 |
| 2021 | - | 8.8M | 1.8M | 2.6M | 6 |
| 2020 | - | 8.9M | 1.5M | 2.3M | 5 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Nordic Pharma Consulting ApS has published its annual report for 2023. Gross profit came to DKK 11,213,012, and the net result was DKK 1,588,832.
About Nordic Pharma Consulting ApS
Nordic Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2016. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Bill Madsen and Ray David Sossna. The company is owned by Bill Holding ApS and by.david ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 15,902,080 and a net result of DKK 3,684,788 compared with DKK 2,966,376 the year before. Equity in the 2025 report amounted to DKK 4,487,385.